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High altitude (HA) hypoxia is a potent activator of the sympathetic nervous system,
eliciting increases in sympathetic vasomotor activity. Microneurographic evidence of
HA sympathoexcitation dates back to the late 20th century, yet only recently have
the characteristics and underpinning mechanisms been explored in detail. This review
summarises recent findings and highlights the importance of HA sympathoexcitation
for the regulation of blood pressure in lowlanders and indigenous highlanders. In
addition, this review identifies gaps in our knowledge and corresponding avenues for
future study.
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1 INTRODUCTION
High altitude (HA) exposure is a significant stressor of cardio-
vascular function and autonomic regulation. Acutely, activation of
the peripheral chemoreceptors increases heart rate and cardiac
output as a means to preserve systemic oxygen delivery. Acute
hypoxic exposure also increases sympathetic vasomotor outflow to
the skeletal muscle vasculature (muscle sympathetic nerve activity;
MSNA) (Saito et al., 1988) to restrain local vasodilator mechanisms
(Weisbrod et al., 2001). With extended exposure to HA, several
time-dependent acclimatisation processes occur, including ventilatory
and haematological alterations, which progressively restore arterial
oxygen content (CaO2 ) and normalise cardiac output to sea-level
values (Sutton et al., 1988). Paradoxically, HA acclimatisation is not
accompanied by normalisation ofMSNA.
In the first published microneurographic study at HA, Duplain et al.,
(1999) reported an augmented MSNA burst frequency following 24–
36 h at 4559 m. This was greater than that observed during 20 min
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exposure to an equivalent hypoxic stimulus (FIO2 0.12) in the same
participants, which suggested MSNA is augmented in response to
increasing durations of exposure. Subsequently, Hansen and Sander,
(2003) reported a 200% increase in MSNA burst frequency following
4weeks’ residence at 5260m, which occurred alongside normalisation
of CaO2 . Furthermore, elevated MSNA persisted for 3 days following
descent to sea level. These seminal studies were followed by a 15-year
hiatus in published HA microneurographic data. Recently, however, a
number of studies have presented new data, including the first MSNA
recordings in highlandnative populations, and address themechanisms
underpinning HA sympathoexcitation. This recent work provides the
primary focus for this Hot Topics Review.
2 SYMPATHETIC NEURAL ACTIVITY AT HA
Sustained sympathoexcitation in lowlanders duringHA acclimatisation
hasbeen confirmedbyourselves andothers (Fisher et al., 2018; Lundby
Experimental Physiology. 2020;1–8. wileyonlinelibrary.com/journal/eph 1
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et al., 2017; Simpson et al., 2019). Furthermore, it is evident that
heightened sympathetic vasomotor outflow is mediated by increases
in both burst frequency and burst size (Busch et al., 2020; Simpson
et al., 2019), and the extent of HA sympathoexcitation is influenced
by the severity of hypoxic stress (Fisher et al., 2018; Table 1). In
the only serial measurements recorded at HA, Lundby et al., (2017)
reported a 180% increase in MSNA burst frequency in lowlanders
following 10 days at 4100 m (15 vs. 42 bursts min–1), with no further
change following 50 days, providing important temporal information
regarding the MSNA response at HA. The large inter-individual
variability in basal MSNA and sympathetic responsiveness to hypo-
xia, in addition to the different ascent profiles and between-laboratory
variability in analysis methods, make direct comparisons between
studies difficult. Nevertheless, in newly exposed lowlanders, MSNA
appears to progressively increase during the initial days at HA, plateau
within 10 days of exposure, and is maintained for the duration of
exposure, at least up to 50 days (Figure 1). This is noteworthy, as
ventilatory, haematological and cardiac responses to HA are dynamic
across the acclimatisation process, whereas sympathoexcitation is
persistent.
Despite acclimatisation, lowlanders exhibit a limited ability to
adapt to HA. In contrast, highland indigenous populations have
adapted over many generations, with divergent adaptation strategies
apparent between populations (Beall, 2006). For example, natives of
the South American Andes primarily rely on increased haemoglobin
levels, and thus high CaO2 , to maintain oxygen delivery to tissues. In
contrast, Himalayan Sherpa appear to rely on enhanced peripheral
blood flow and downstream metabolic adaptations to meet oxygen
demand (Erzurum et al., 2007; Horscroft et al., 2017). Sympathetic
neural activity, which is an important regulator of systemic and peri-
pheral blood flow, may contribute to these phenotypical differences.
However, until recently, very little was known regarding sympathetic
New Findings
∙ What is the topic of the review?
Sympathoexcitation and sympathetic control of
blood pressure at high altitude.
∙ What advances does it highlight?
Sustained sympathoexcitation is fundamental to
integrative control of blood pressure in humans
exposed to chronic hypoxia. The largest gaps
in current knowledge are in understanding the
complex mechanisms by which central sympathetic
outflow is regulated at high altitude.
neural activity in highlanders, due to the lack of microneurographic
data.
Lundby and colleagues (2017) reported comparable MSNA burst
frequencies in Bolivian Aymara Andean highlanders and lowlanders
following 10 days at 4100 m, which was two-fold higher than that
of lowlanders at sea-level (Figure 1). In contrast, Sherpa exhibit
MSNA burst frequencies that are 73% lower than those observed
in lowlanders following 10–20 days at HA. (Simpson et al., 2019;
Figure 1). Furthermore,MSNAburst frequency is 70% lower in Sherpa,
when compared with values obtained in Andean highlanders of a
similar age and body mass index (Lundby et al., 2017). Strikingly, this
is despite Andeans been studied at a lower altitude (4100 vs. 5050
m) and exhibiting greater oxygen saturations (87 vs. 82%). Whilst
several factors, independent of genotypic differences, can influence
MSNA (i.e., physical activity, diet and environmental factors) (Notay
et al., 2017), these findings indicate that divergent pathways of
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lowlanders (27± 6 years)
Active 10–20 days 5050m 173% increase LA; 84± 2,
HA; 85± 3
NS
Due to large inter-individual variability in basal MSNA at sea level, the relative change inMSNA for lowlanders at HA versus sea level are displayed. HA, high
altitude; LA, low altitude;MAP, mean arterial pressure;MSNA, muscle sympathetic nerve activity; NS, non-significant.
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F IGURE 1 Summary of the changes in muscle sympathetic nerve activity (MSNA) burst frequency during acclimatisation in lowlanders and
adaptation in highland natives. Values presented asmeans± SEM. †Andeans with chronic mountain sickness
adaptation extend to the sympathetic neural response to HA. In other
words, Sherpa have adapted to favour a lower sympathetic vasomotor
outflow than Andeans. Whilst the benefits of lower sympathetic vaso-
motor outflow are unclear, this may facilitate augmented peripheral
blood flow (Erzurum et al., 2007), and protect against the potentially
negative vascular consequences associated with chronically elevated
sympathetic vasomotor activity (Malpas, 2010). Nevertheless, MSNA
for Sherpa at 5050 m was ∼30% greater than that observed for
Sherpa at 1440 m (Simpson et al., 2019), indicating that HA hypo-
xia remains a potent sympathetic stressor, despite evolutionary
adaptation.
Themajority of highland natives demonstrate successful adaptation
to theHAenvironment; however, a small percentage of individuals lack
the ability to adapt, and develop the maladaptation syndrome chronic
mountain sickness (CMS). CMS, which is most prevalent (>15%) in
Andean highlanders (Leon-Velarde et al., 2005), is characterised by an
excessive haematological response to ambient hypoxia (haemoglobin
concentration ≥21 g/dl for men, ≥19 g/dl for women) and exaggerated
arterial hypoxaemia for the resident altitude (Leon-Velarde et al.,
2005). Excessive erythrocyte volume, and the resulting elevations in
haematocrit and blood viscosity, increase resistance to blood flow,
exacerbate ventilation–perfusion mismatch and impair pulmonary gas
exchange (Winslow et al., 1985), which further exacerbates arterial
hypoxaemia. Despite lower arterial oxygen tensions and saturations,
Simpson et al (2021) reported a 25% lower MSNA burst frequency
in Andeans with mild CMS, compared to healthy Andean highlanders
(Figure 1). Whether this is also true for more severe cases of CMS
remains unclear and a direction for future study.
Whilst it must be acknowledged that these studies involve small
samples, sympathetic activation appears to be a feature of HA
exposure in both lowlanders and highlanders. However, duration of
altitude residence, elevation, ascent profile, ethnicity and presence
or absence of CMS likely influence the degree of sympathoexcitation.
There may be a fundamental regulatory role for heightened MSNA
at HA, which is to maintain systemic vasomotor tone and arterial
pressure.
3 ARTERIAL BLOOD PRESSURE REGULATION
AT HA
3.1 Baroreflex control of sympathetic vasomotor
activity
The arterial baroreflex is the preeminent short-term controller
of arterial blood pressure, primarily via beat-to-beat changes in
sympathetic vasomotor outflow and i.e. MSNA. Observations that
heightened MSNA (between 75% and 200%) is accompanied by a
small elevation in resting arterial pressure (4–14%; Table 1) led
to a suggestion that baroreflex control of MSNA is impaired by
chronic exposure to ambient hypoxia (Fisher et al., 2018; Hansen
and Sander, 2003; Lundby et al., 2017). This hypothesis was recently
tested, utilising pharmacologically induced changes in blood pressure
(modifiedOxford test) (Simpsonet al., 2019).However,whilst exposure
to acute normobaric hypoxia (FIO2 0.11) reduced vascular sympathetic
baroreflex responsiveness, there was no evidence that vascular
sympathetic baroreflex responsiveness (i.e., gain) was different at
5050 m (10–20 days’ exposure) compared with low altitude (LA;
344 m). Furthermore, vascular sympathetic baroreflex gain for Sherpa
was comparable with lowlanders, and resting arterial blood pressure
was remarkably similar for both groups at HA and for lowlanders
at LA. Despite similarities in baroreflex gain and arterial pressure,
the vascular sympathetic baroreflex operated at a different MSNA
operating point (i.e.,MSNAburst incidence). For lowlanders, theMSNA
operating point was higher at 5050m compared with LA, indicating an
upward resetting of the vascular sympathetic baroreflex. For Sherpa,
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the vascular sympathetic baroreflex operating pointwas lower than for
lowlanders at 5050m, yet higher than for lowlanders at LA.
Using the same approach, vascular sympathetic baroreflex function
has also been explored in Peruvian Andeans of Quechan ancestry,
with and without CMS (Simpson et al., 2021). Unexpectedly, vascular
sympathetic baroreflex responsiveness was similar in both groups. In
addition, reflex gains were similar to those observed previously for
lowlanders and Sherpa (Simpson et al., 2019). Furthermore, despite
considerable variability in basal MSNA across populations, arterial
pressure was similar for lowlanders, Sherpa and Andeans. Collectively,
these findings indicate that the ability of the baroreflex to regulate
MSNA is not impaired under the physiological stress of HA hypo-
xia, even with the presence of CMS. In fact, the vascular sympathetic
baroreflex is equally effective at buffering beat-by-beat fluctuations
in arterial pressure among lowlanders and highlanders, at least during
moderate blood pressure challenges (±15 mmHg above and below
resting arterial pressure). Nevertheless, the vascular sympathetic
baroreflex operates with a higher MSNA operating point to maintain
arterial pressure at HA. Whether the higher operating point limits the
vasoconstrictor response to initial orthostatic hypotension, due to a
reduced sympathetic reserve, remains to be determined.
In addition to sympathetic vasomotor outflow, arterial blood
pressure is also determined by local vascular control mechanisms,
cardiac output and blood volume (Guyenet, 2006), which all change, to
varying degrees, in response toHAexposure. It is, therefore, important
to examine the shift in baroreflex MSNA operating point and elevated
basalMSNA in the context of these other factors.
3.2 Vascular control mechanisms
Augmented MSNA counteracts vasodilatory mechanisms during
systemic hypoxia (Weisbrod et al., 2001) and may offset blunted
neurovascular transduction (i.e., vasoconstrictor response to a burst
of MSNA). Indeed, Berthelsen et al., (2020) reported a blunted pressor
response following a burst of MSNA in lowlanders at HA, compared
to LA. Moreover, Sherpa exhibit a greater pressor response to a burst
of MSNA at HA, whereas Andeans exhibit a smaller pressor response
compared to both lowlanders and Sherpa at HA. Furthermore, in the
same groups of participants, Busch et al (2020) reported a greater
pressor response toMSNA in Sherpa duringmaximal apnoea, although
this was not replicated during isometric handgrip.
Down-regulation of cardiac β-adrenergic receptor sensitivity
is observed during chronic HA exposure in lowlanders (Richalet
et al., 1988), and similar adrenergic desensitisation or decreased
responsiveness may occur within the vasculature, mediating
the reduced neurovascular transduction. Simpson et al., (2019)
reported that an identical dose of an α1-adrenergic receptor agonist,
phenylephrine, elicited a lower pressor response following 10–20 days
at 5050 m compared to 344 m, indicating a reduced α1-adrenergic
receptor sensitivity. Moreover, in Sherpa at 5050 m, a similar pre-
ssor response was elicited by a smaller dose of phenylephrine,
compared to lowlanders at 5050 m. Overall, augmented MSNA in
lowlanders at HA is possibly a compensatory response to blunted
neurovascular transduction, and population differences in basal
MSNA, without substantial variation in resting arterial pressure, may
reflect differences in vascular sensitivity to MSNA. Nevertheless,
pharmacological investigations would be required to determine this
possibility. Furthermore, it remains to be determined whether, in
fact, neurovascular transduction is blunted as a response to elevated
MSNA.
3.3 Circulating blood volume
It has previously been suggested that sympathetic vasomotor outflow
is augmented in lowlanders at HA to compensate for a reduction in
circulating blood volume (Hansen and Sander, 2003). Blood volume
depletion, secondary to reductions in plasma volume, begins within
24h atHAand serves as an adaptive response to increase haemoglobin
concentration early during exposure (Ryan et al., 2014). Despite
progressive expansion of erythrocyte volume after 7 days at altitude
(Ryan et al., 2014), blood volume remains reduced during the first
4 weeks of exposure (Siebenmann et al., 2017). Acute reductions
in blood volume exert an excitatory influence on sympathetic vaso-
motor outflow, via engagement of the arterial baroreflex, with the
observation of an inverse relationship between these factors in healthy
males at sea level (Best et al., 2014). Indeed, briefly restoring blood
volume, via 1000 ml saline infusion, elicits a 20% reduction in MSNA
burst frequency in lowlanders following 4 weeks at 5260 m (Hansen
and Sander, 2003). Nevertheless, despite restoration of blood volume,
MSNA remained significantly elevated above sea level values (∼150%),
suggesting other important contributory mechanisms. Stembridge
et al., (2019) demonstrated a greater total blood volume in Sherpa,
compared to acclimatising lowlanders, at 5050 m, with Sherpa also
exhibiting lower MSNA (Simpson et al., 2019). Moreover, Andeans
with mild CMS exhibit a 20% greater total blood volume, secondary
to an increased erythrocyte volume, compared to healthy Andeans
(Claydon et al., 2004; Simpson et al., 2021). This greater blood volume
corresponded to25% lowerMSNA, leading toa conclusion that relative
sympathoinhibition in mild CMS balances haemodynamic effects of
excessive erythrocytosis (i.e., elevated blood volume and blood visco-
sity) and maintains arterial pressure within a normal range (Simpson
et al., 2021). Nevertheless, direct manipulation of blood volume is
required to investigate its role inMSNA regulation in highlanders.
In summary, arterial blood pressure at HA is determined by
integration of several physiological factors. An upward shift in
baroreflex MSNA operating point and ensuing sympathoexcitation
appear to be part of an integrated response to HA exposure, which
work to maintain both oxygen and arterial pressure homeostasis.
Indeed, the absence of such elevations in MSNA at HA, particularly
in recently exposed lowlanders, could lead to hypotension, decreasing
perfusion of vital organs and exacerbating an already compromised
oxygen delivery.
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4 MECHANISMS INVOLVED IN NEURAL
ADJUSTMENTS TO HA
Themechanisms underlying the neural adjustments toHA, which likely
involve alterations in peripheral feedback and central regulatory
mechanisms, have not been interrogated fully. The remaining
section considers the mechanistic contribution of autonomic reflexes
originating from peripheral chemoreceptors and pulmonary arterial
baroreceptors to vascular sympathetic baroreflex resetting and
sympathoexcitation at HA.
4.1 Peripheral chemoreceptors
Carotid body sensitisation and enhanced translation of chemoreceptor
afferent input to the central nervous system are responsible for
a time-dependent increase in ventilation in lowlanders exposed to
chronic HA hypoxia (i.e., ventilatory acclimatisation). The ventilatory
and sympathetic chemoreflex share a common afferent pathway
(Guyenet, 2000); thus, it is reasonable to consider a role for peri-
pheral chemoreceptors in sympathoexcitation during sustained HA
hypoxia (Dempsey et al., 2014). Nevertheless, attempts to acutely
eliminate peripheral chemoreflex drive at HA indicate the effect on
basal MSNA is modest or evenminimal. For example, Hansen & Sander
(2003) reported that 25 min of hyperoxia reduced basal MSNA by
7 bursts min–1 (∼20%), following 4 weeks’ acclimatization at 5260 m.
Notably, sympathetic vasoconstrictor drive remained substantially
elevated compared to sea level values (∼175%). Following a shorter
sojourn (10–20 days) at 5050 m, minimal change in MSNA burst
frequency and total activity were observed when breathing 100% O2
for 5 min (Simpson et al., 2019). Furthermore, there was no change
in vascular sympathetic baroreflex function (i.e., MSNA operating
point, operating pressure and gain). Similarly to lowlanders, hyper-
oxia does not significantly influence vascular sympathetic baroreflex
function in Andean highlanders nor Nepalese Sherpa, and has minimal
effects upon basal MSNA at HA (Simpson et al., 2019; Simpson
et al., 2021). In this study, hyperoxia duration was relatively brief,
in order to eliminate peripheral chemoreceptor drive whilst mini-
mising secondary effects of changes in CO2 and minute ventilation.
Fisher et al. (2018) also observed that blunting carotid chemoreceptor
drive, via low-dose intravenous dopamine infusion, did not change
MSNA in lowlanders after 15–17 days at 3454 m; however, systemic
effects of dopamine complicate the interpretation of these findings.
Nevertheless, it is evident that whilst the peripheral chemoreflex
appears to be central in initiating sympathoexcitation during acute
hypoxic exposures, the peripheral chemoreflex is not solely responsible
for sustained sympathoexcitation during HA acclimatisation and
adaptation. Importantly, there appears to be a dissociation between
ventilatory and sympathetic responses during chronic hypoxia , a
notion that is supported by recent studies of peripheral chemoreflex
activation during acute hypoxia (Keir et al., 2019; Prasad et al., 2020).
Nevertheless, the relative contribution of the peripheral chemoreflex
mechanism to basal MSNA appears to vary between lowlanders,
Andeans and Sherpa, whichmay be influenced by ancestral differences
in peripheral chemoreceptor sensitivity to hypoxia (Beall et al., 1997;
Severinghaus et al 1966).
4.2 Pulmonary arterial baroreceptors
In response to ambient hypoxia, the pulmonary vascular smooth
muscle contracts, elevating pulmonary arterial vascular resistance
and pressure (Groves et al., 1987). Notably, the seminal work
by Duplain et al., (1999) reported a strong, positive relationship
between pulmonary arterial pressure (PAP) and MSNA burst
frequency. Furthermore, in normoxic anesthetised animals, iso-
lated increases in PAP elicit increases in sympathetic outflow in a
positive feedback manner, via stimulation of baroreceptors located
in the extra pulmonary arteries (Moore et al., 2011). The potential
sympathoexcitatory role of pulmonary arterial baroreceptors in
humans at HA has since been investigated (Simpson et al., 2020).
During inhalation of vasodilator nitric oxide, which selectively lowered
PAP by 25%, a similar reduction in MSNA burst frequency was
observed in lowlanders at 4383 m (exposure range 4–9 days). This
reduction in MSNA corresponded to a downward and leftward
resetting of the vascular sympathetic baroreflex. These findings
support a hypothesis that afferent feedback from pulmonary arterial
baroreceptors contributes to resetting of baroreflex control of
MSNA and sympathoexcitation at HA. Additionally, incomplete
reversal of PAP elevations following return to LA (Groves et al., 1987;
Maufrais et al., 2016) may contribute to maintained elevations in
MSNA following descent (Hansen and Sander 2003; Mitchell et al.,
2018). It is less evident how pulmonary arterial baroreceptors might
contribute to sympathetic control of blood pressure for indigenous
high-altitude populations. However, it is noteworthy that Sherpa, for
whom basal MSNA is lower compared with lowlanders and Andeans
at HA, display minimal hypoxic pulmonary hypertension (Groves
et al., 1993). Therefore, differences in PAP may contribute to the
differences in vascular sympathetic baroreflex MSNA operating
point and basal MSNA between populations. Similarly to other
mechanisms investigated, the magnitude of the reduction in MSNA
during reductions in PAPwas relativelymodest (Figure 2). It is possible,
however, that a greater reduction in PAP (i.e., to sea level values) would
have elicited a greater reduction inMSNA.
Overall, HA exposure is accompanied by alterations in afferent
input to several peripheral reflexes, including those originating
from the peripheral chemoreceptors, arterial baroreceptors (in
response to a reduction in blood volume) and pulmonary arterial
baroreceptors (in response to elevated PAP). These autonomic
reflexes all contribute to sustained sympathoexcitation at HA
(Figure 2). Whilst the mechanistic contribution of these reflexes
appear to vary with exposure duration, and may be influenced by
ancestry, they account for ∼70% of the increase in basal MSNA
(Figure 2) in acclimatising lowlanders. The mechanisms accounting for
the remaining ∼30% of HA sympathoexcitation require investigation,
with candidate mechanisms including alterations in central nitric
6 SIMPSON ET AL
F IGURE 2 Mechanisms for high altitude (HA) sympathoexcitation. Alterations in afferent input to several peripheral reflexes contribute to
elevated basalMSNA at HA, as shown in (a). The approximate contributions of each peripheral reflex mechanism, based on the studies described in
section 2 and 3, are shown in (b). Additional mechanisms contributing to HA sympathoexcitationmay include alterations in circulating factors and
direct inputs to the sympathetic vasomotor control centres. CMS, chronic mountain sickness
oxide bioavailability, systemic inflammation and oxidative stress
(Lewis et al., 2014), central erythropoietin production (Oshima
et al., 2018), and alterations in intracranial pressure (Schmidt et al.,
2018) (Figure 2). Moreover, whilst the contribution of the peripheral
chemoreflex to HA sympathoexcitation in highlanders has been
examined, the relative contribution of additional mechanisms requires
investigation.
5 CONCLUSION
Sympathoexcitation is a featureofHAexposure, not only in lowlanders,
but also inhighlandnativeswhohavegenerational exposure toambient
hypoxia. A shift to a higher baroreflex MSNA operating point permits
elevated MSNA at HA, whilst maintaining the ability to buffer acute
changes in arterial pressure. ElevatedMSNA is a functional adaptation,
compensating for alterations in vascular control mechanisms and
blood volume,which protect against hypotension, andmaintain oxygen
demand at HA, especially in lowlanders. These neural adjustments
likely involve a complex integration of multiple mechanisms, whose
contribution may change as a function of duration of HA exposure.
Indeed, the peripheral chemoreflex appears to be the primary
mechanism responsible for the initiation of elevated sympathetic vaso-
motor outflow during acute hypoxic exposures; however, additional
mechanisms, including alterations in blood volume and afferent input
from pulmonary arterial baroreceptors, contribute to augmented
sympathetic vasomotor outflow during sustained exposures. Despite
these recent advances, future studies are necessary to determine
the precise physiological mechanisms by which chronic HA hypo-
xia promotes sympathetic vascular baroreflex resetting and elevated
sympathetic vasomotor outflow. Moreover, greater female inclusion is
required for examination of potential sex differences in sympathetic
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